Back to search
FDAFDA · Food and drugs·Recall number D-926-2013

Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01

Published September 4, 2013 · Recall initiated: August 12, 2013

Summary

FDA records drug Class II recall D-926-2013, published September 4, 2013 and initiated August 12, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 345,800 vials; Lot: Lot 25048DK Exp. 01/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if KETOROLAC TROMETHAMINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
KETOROLAC TROMETHAMINE
Manufacturer
Hospira, Inc.
Distributor
Naitonwide
Lot
Lot 25048DK Exp. 01/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01 recalled?

Yes. FDA published recall D-926-2013 on September 4, 2013. Reported hazard: Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE.